• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy.

作者信息

Sieja Kevin S, Everson Gregory T

机构信息

Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, Denver, Colorado 80220, USA.

出版信息

Dig Dis Sci. 2006 Mar;51(3):600-2. doi: 10.1007/s10620-006-3176-1.

DOI:10.1007/s10620-006-3176-1
PMID:16614973
Abstract
摘要

相似文献

1
De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy.
Dig Dis Sci. 2006 Mar;51(3):600-2. doi: 10.1007/s10620-006-3176-1.
2
Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.天冬氨酸转氨酶与血小板比值指数和持续病毒学应答与聚乙二醇干扰素加利巴韦林治疗后丙型肝炎相关性肝硬化进展为肝细胞癌相关。
Clin Interv Aging. 2016 Aug 1;11:1035-41. doi: 10.2147/CIA.S108589. eCollection 2016.
3
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus.索非布韦/利巴韦林治疗日本 2 型丙型肝炎病毒时，肝癌或干扰素治疗史会减弱疗效。
World J Gastroenterol. 2018 Apr 7;24(13):1478-1485. doi: 10.3748/wjg.v24.i13.1478.
4
Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis.持续病毒学应答对 HCV 肝硬化患者肝细胞癌发生率的影响。
Braz J Infect Dis. 2010 Sep-Oct;14(5):457-61.
5
Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.在接受包括干扰素在内的抗病毒治疗后获得持续病毒学应答的慢性丙型肝炎患者，在接受肝细胞癌肝切除术前的良好预后。
Anticancer Res. 2015 Dec;35(12):6963-9.
6
Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after sustained virological response.丙型肝炎病毒感染患者持续病毒学应答后肝细胞癌的早期发生和复发
Hepatol Int. 2018 Mar;12(2):90-93. doi: 10.1007/s12072-018-9862-1. Epub 2018 Apr 4.
7
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.慢性丙型肝炎合并重度肝纤维化患者的持续病毒学应答及临床结局
Ann Intern Med. 2007 Nov 20;147(10):677-84. doi: 10.7326/0003-4819-147-10-200711200-00003.
8
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study.在AMBER真实世界经验研究中，使用ombitasvir/paritaprevir/ritonavir±dasabuvir±利巴韦林治疗2年后的病毒学应答持久性、新发肝细胞癌风险、肝功能和肝硬度
J Viral Hepat. 2018 Nov;25(11):1298-1305. doi: 10.1111/jvh.12945. Epub 2018 Jul 3.
9
Summaries for patients. Sustained virologic response in hepatitis C.患者摘要。丙型肝炎的持续病毒学应答
Ann Intern Med. 2007 Nov 20;147(10):I47. doi: 10.7326/0003-4819-147-10-200711200-00001.
10
Comment on: "Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis".关于《丙型肝炎病毒肝硬化患者持续病毒学应答对肝细胞癌发生率的影响》的评论
Braz J Infect Dis. 2011 Jul-Aug;15(4):410.

引用本文的文献

1
Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C.在对慢性丙型肝炎进行干扰素治疗获得6年持续病毒学应答后，发生了肝内胆管细胞癌和肝细胞癌。
Clin J Gastroenterol. 2011 Jun;4(3):167-173. doi: 10.1007/s12328-011-0216-y. Epub 2011 Mar 24.
2
Long-term effects of antiviral therapy in patients with chronic hepatitis C.慢性丙型肝炎患者抗病毒治疗的长期效果
Hepat Res Treat. 2010;2010:562578. doi: 10.1155/2010/562578. Epub 2010 Sep 27.
3
Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports.

本文引用的文献

1
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.在接受干扰素治疗获得持续应答后发生肝细胞癌的慢性丙型肝炎患者的特征。
Cancer. 2004 Oct 1;101(7):1616-22. doi: 10.1002/cncr.20537.
2
Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.等待肝移植的丙型肝炎病毒感染患者的肝细胞癌：与肿瘤进展相关的基因
Liver Transpl. 2004 May;10(5):607-20. doi: 10.1002/lt.20118.
3
Hepatocellular carcinoma and hepatitis C in the United States.
丙型肝炎病毒清除后且无肝硬化的4型丙型肝炎相关肝细胞癌：两例报告
Cases J. 2009 Sep 15;2:7927. doi: 10.1186/1757-1626-0002-0000007927.
4
Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy.肝活检提示无肝硬化的丙型肝炎患者经治疗后病毒学应答持续，其后发生肝细胞癌。
Eur J Gastroenterol Hepatol. 2009 Feb;21(2):225-9. doi: 10.1097/MEG.0b013e32831101b7.
美国的肝细胞癌与丙型肝炎
Hepatology. 2002 Nov;36(5 Suppl 1):S74-83. doi: 10.1053/jhep.2002.36807.
4
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.干扰素与病毒性肝硬化肝细胞癌的预防：循证医学方法
J Hepatol. 2001 Apr;34(4):593-602. doi: 10.1016/s0168-8278(01)00005-8.
5
Development of small hepatocellular carcinoma 80 months after clearance of hepatitis C virus with interferon therapy.
Eur J Gastroenterol Hepatol. 2000 Sep;12(9):1029-32. doi: 10.1097/00042737-200012090-00012.
6
Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma.在日本，大多数肝硬化患者死于肝细胞癌。
Oncol Rep. 1999 Nov-Dec;6(6):1273-6. doi: 10.3892/or.6.6.1273.
7
Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.干扰素治疗可降低肝细胞癌风险：日本慢性丙型肝炎肝硬化和非肝硬化患者的全国监测项目。IHIT研究组。干扰素治疗对肝癌发生的抑制作用。
Ann Intern Med. 1999 Aug 3;131(3):174-81. doi: 10.7326/0003-4819-131-3-199908030-00003.
8
Hepatitis C and hepatocellular carcinoma.丙型肝炎与肝细胞癌。
Hepatology. 1997 Sep;26(3 Suppl 1):34S-38S. doi: 10.1002/hep.510260706.
9
Suppression of apoptotic cell death by hepatitis C virus core protein.
Virology. 1996 Dec 15;226(2):176-82. doi: 10.1006/viro.1996.0644.
10
Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: clinical study of 26 cases.慢性丙型肝炎干扰素治疗后肝细胞癌的检测：26例临床研究
J Gastroenterol Hepatol. 1996 Jun;11(6):535-9. doi: 10.1111/j.1440-1746.1996.tb01698.x.